What they were paid
Inhibrx Biosciences Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $63,000 | — | $139,685 | — | $202,685 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Inhibrx Biosciences, Inc. DEF 14A filed April 23, 2026, accession 0002007919-26-000014, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Inhibrx Biosciences, Inc. filed document, accession 0002007919-26-000014. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.
Get the Inhibrx Biosciences Board Governance Report
$202,685 Douglas G. Forsyth, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Inhibrx Biosciences pays directors a $35,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation · Nominating/Governance (Chair)
The rest of the Inhibrx Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Jon Faiz Kayyem, Ph.D | Independent Director | $192,185 |
| Kimberly Manhard | Independent Director | $183,685 |
| Kristiina Vuori, M.D., Ph.D | Independent Director | $186,185 |
| Mark P. Lappe | Chair of the Board | — |
The full Inhibrx Biosciences compensation record
free company briefThis page is one director within Inhibrx Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Order INBX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.